-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, N0+xE3LMvU+1yC4WyvqbZ571vwvaNYyN6xvL7/xYbYaWF85FssmoohXdtYk9fAb7 1tNsy2nROHNjz82a8h1DnQ== 0001019056-09-001036.txt : 20091021 0001019056-09-001036.hdr.sgml : 20091021 20091021095924 ACCESSION NUMBER: 0001019056-09-001036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091019 FILED AS OF DATE: 20091021 DATE AS OF CHANGE: 20091021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO REFERENCE LABORATORIES INC CENTRAL INDEX KEY: 0000792641 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 222405059 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 481 EDWARD H ROSS DR CITY: ELMWOOD PARK STATE: NJ ZIP: 07407-3118 BUSINESS PHONE: 2017912186 MAIL ADDRESS: STREET 1: 481 EDWARD H ROSS DRIVE CITY: ELMWOOD PARK STATE: NJ ZIP: 07407-3118 FORMER COMPANY: FORMER CONFORMED NAME: MED MOBILE INC DATE OF NAME CHANGE: 19891115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DUBINETT HOWARD CENTRAL INDEX KEY: 0001189454 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15266 FILM NUMBER: 091129312 MAIL ADDRESS: STREET 1: 481B EDWARD H ROSS DRIVE CITY: ELMWOOD PARK STATE: NJ ZIP: 07407 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2009-10-19 0000792641 BIO REFERENCE LABORATORIES INC BRLI 0001189454 DUBINETT HOWARD 481 EDWARD H. ROSS DRIVE ELMWOOD PARK NJ 07407 1 1 0 0 Executive VP, COO Common Stock 2009-10-19 2009-10-19 4 S 0 85803 29.98 D 225069 D In lieu of an outright sale, on October 15, 2007, Howard Dubinett entered into a pre-paid variable price forward sales contract ("Forward Contract") with UBS Securities LLC ("UBS"). Pursuant to the Forward Contract, Mr. Dubinett pledged 89,047 shares of his BRLI Common Stock to secure his obligation to deliver a maximum 89,047 shares of BRLI Common Stock to UBS on October 19, 2009 (the "Settlement Date"). As prepayment for the pledge of the 89,047 shares, UBS paid Mr. Dubinett $2,572,474 or approximately $28.89 per share representing 87.9% of the proceeds from the sale of 89,047 shares of BRLI Common Stock on or about October 16, 2007. The number of shares that Mr. Dubinett was obligated to deliver on the Settlement Date varied based upon the average closing price of the Common Stock on the NASDAQ Global Market System on the four trading days ending on and including the Settlement Date. (Continued - Footnote 2). Mr. Dubinett was entitled to benefit from any excess of such average closing price for BRLI Common Stock between $28.89 per share up to a maximum $39.44 per share by being able to deliver fewer shares. Based on the average closing price on the four trading days, Mr. Dubinett was entitled to the return of 3,244 of the 89,047 pledged shares. The net effect of the transaction to Mr. Dubinett is that he sold 85,803 shares at a price of $29.98 per share. /s/ ROGER TOLINS - Attorney-in-Fact for Howard Dubinett 2009-10-21 -----END PRIVACY-ENHANCED MESSAGE-----